Cargando…

Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice

BACKGROUND: The gut microbiota is playing more important roles in host immune regulation than was initially expected. Since many benefits of microbes are highly strain-specific and their mechanistic details remain largely elusive, further identification of new probiotic bacteria with immunoregulator...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Joon, Yang, Woo, Hostetler, Andrew, Schultz, Nathan, Suckow, Mark A., Stewart, Kay L., Kim, Daniel D., Kim, Hyung Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837529/
https://www.ncbi.nlm.nih.gov/pubmed/27095067
http://dx.doi.org/10.1186/s12866-016-0686-7
_version_ 1782427865372950528
author Lee, Joon
Yang, Woo
Hostetler, Andrew
Schultz, Nathan
Suckow, Mark A.
Stewart, Kay L.
Kim, Daniel D.
Kim, Hyung Soo
author_facet Lee, Joon
Yang, Woo
Hostetler, Andrew
Schultz, Nathan
Suckow, Mark A.
Stewart, Kay L.
Kim, Daniel D.
Kim, Hyung Soo
author_sort Lee, Joon
collection PubMed
description BACKGROUND: The gut microbiota is playing more important roles in host immune regulation than was initially expected. Since many benefits of microbes are highly strain-specific and their mechanistic details remain largely elusive, further identification of new probiotic bacteria with immunoregulatory potentials is of great interest. RESULTS: We have screened our collection of probiotic lactic acid bacteria (LAB) for their efficacy in modulating host immune response. Some LAB are characterized by suppression of TNF-α induction when LAB culture supernatants are added to THP-1 cells, demonstrating the LAB’s anti-inflammatory potential. These suppressive materials were not inactivated by heat or trypsin. On the other hand, treatment of THP-1 directly with live bacterial cells identified a group of pro-inflammatory LAB, which stimulated significant production of TNF-α. Among those, we chose the Lactobacillus reuteri BM36301 as an anti-inflammatory strain and the L. reuteri BM36304 as a pro-inflammatory strain, and further studied their in vivo effects. We supplied C57BL/6 mice with these bacteria in drinking water while feeding them a standard diet for 20 weeks. Interestingly, these L. reuteri strains evoked different consequences depending on the gender of the mice. That is, males treated with anti-inflammatory BM36301 experienced less weight gain and higher testosterone level; females treated with BM36301 maintained lower serum TNF-α as well as healthy skin with active folliculogenesis and hair growth. Furthermore, while males treated with pro-inflammatory BM36304 developed higher serum levels of TNF-α and insulin, in contrast females did not experience such effects from this bacteria strain. CONCLUSION: The L. reuteri BM36301 was selected as an anti-inflammatory strain in vitro. It helped mice maintain healthy conditions as they aged. These findings propose the L. reuteri BM36301 as a potential probiotic strain to improve various aspects of aging issues. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-016-0686-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4837529
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48375292016-04-21 Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice Lee, Joon Yang, Woo Hostetler, Andrew Schultz, Nathan Suckow, Mark A. Stewart, Kay L. Kim, Daniel D. Kim, Hyung Soo BMC Microbiol Research Article BACKGROUND: The gut microbiota is playing more important roles in host immune regulation than was initially expected. Since many benefits of microbes are highly strain-specific and their mechanistic details remain largely elusive, further identification of new probiotic bacteria with immunoregulatory potentials is of great interest. RESULTS: We have screened our collection of probiotic lactic acid bacteria (LAB) for their efficacy in modulating host immune response. Some LAB are characterized by suppression of TNF-α induction when LAB culture supernatants are added to THP-1 cells, demonstrating the LAB’s anti-inflammatory potential. These suppressive materials were not inactivated by heat or trypsin. On the other hand, treatment of THP-1 directly with live bacterial cells identified a group of pro-inflammatory LAB, which stimulated significant production of TNF-α. Among those, we chose the Lactobacillus reuteri BM36301 as an anti-inflammatory strain and the L. reuteri BM36304 as a pro-inflammatory strain, and further studied their in vivo effects. We supplied C57BL/6 mice with these bacteria in drinking water while feeding them a standard diet for 20 weeks. Interestingly, these L. reuteri strains evoked different consequences depending on the gender of the mice. That is, males treated with anti-inflammatory BM36301 experienced less weight gain and higher testosterone level; females treated with BM36301 maintained lower serum TNF-α as well as healthy skin with active folliculogenesis and hair growth. Furthermore, while males treated with pro-inflammatory BM36304 developed higher serum levels of TNF-α and insulin, in contrast females did not experience such effects from this bacteria strain. CONCLUSION: The L. reuteri BM36301 was selected as an anti-inflammatory strain in vitro. It helped mice maintain healthy conditions as they aged. These findings propose the L. reuteri BM36301 as a potential probiotic strain to improve various aspects of aging issues. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-016-0686-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-19 /pmc/articles/PMC4837529/ /pubmed/27095067 http://dx.doi.org/10.1186/s12866-016-0686-7 Text en © Lee et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Lee, Joon
Yang, Woo
Hostetler, Andrew
Schultz, Nathan
Suckow, Mark A.
Stewart, Kay L.
Kim, Daniel D.
Kim, Hyung Soo
Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice
title Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice
title_full Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice
title_fullStr Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice
title_full_unstemmed Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice
title_short Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice
title_sort characterization of the anti-inflammatory lactobacillus reuteri bm36301 and its probiotic benefits on aged mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837529/
https://www.ncbi.nlm.nih.gov/pubmed/27095067
http://dx.doi.org/10.1186/s12866-016-0686-7
work_keys_str_mv AT leejoon characterizationoftheantiinflammatorylactobacillusreuteribm36301anditsprobioticbenefitsonagedmice
AT yangwoo characterizationoftheantiinflammatorylactobacillusreuteribm36301anditsprobioticbenefitsonagedmice
AT hostetlerandrew characterizationoftheantiinflammatorylactobacillusreuteribm36301anditsprobioticbenefitsonagedmice
AT schultznathan characterizationoftheantiinflammatorylactobacillusreuteribm36301anditsprobioticbenefitsonagedmice
AT suckowmarka characterizationoftheantiinflammatorylactobacillusreuteribm36301anditsprobioticbenefitsonagedmice
AT stewartkayl characterizationoftheantiinflammatorylactobacillusreuteribm36301anditsprobioticbenefitsonagedmice
AT kimdanield characterizationoftheantiinflammatorylactobacillusreuteribm36301anditsprobioticbenefitsonagedmice
AT kimhyungsoo characterizationoftheantiinflammatorylactobacillusreuteribm36301anditsprobioticbenefitsonagedmice